Cargando…

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer

JARID1B, a histone demethylase, has been reported to be highly expressed in various human cancers. In the present study, we investigated the association of JARID1B level with epithelial ovarian cancer (EOC) and prognosis of patients with EOC. We analyzed JARID1B expression in 20 normal ovaries, 20 b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lishuang, Mao, Yuanfu, Du, Guiqin, He, Chunbo, Han, Shiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428534/ https://www.ncbi.nlm.nih.gov/pubmed/25663457 http://dx.doi.org/10.1007/s13277-014-2859-z

Ejemplares similares

Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
por: Shigekawa, Yoshinobu, et al.
Publicado: (2018)

Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2020)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma
por: Xu, Lu, et al.
Publicado: (2019)

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
por: Liu, Longyang, et al.
Publicado: (2019)

Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer
por: Yang, Fengmei, et al.
Publicado: (2018)

SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
por: Zhang, Peng-Fei, et al.
Publicado: (2019)

Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
por: Liu, Zhaoxia, et al.
Publicado: (2016)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway
por: Gao, Yan, et al.
Publicado: (2020)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer
por: Liu, Longyang, et al.
Publicado: (2022)

Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer
por: Liu, Shaoqiu, et al.
Publicado: (2021)

Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer
por: Wang, Jinghao, et al.
Publicado: (2018)

High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2023)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020)

SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer
por: Lou, Jiayan, et al.
Publicado: (2022)

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
por: Wen, Ning, et al.
Publicado: (2014)

Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
por: Li, Weiping, et al.
Publicado: (2012)

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer
por: Xu, Zongbin, et al.
Publicado: (2019)

Inactive yet indispensable: the tale of Jarid2
por: Landeira, David, et al.
Publicado: (2011)

JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2015)

14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer
por: Kim, Hyun-Jung, et al.
Publicado: (2018)

Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
por: Jiang, Senwei, et al.
Publicado: (2022)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma
por: Zhang, Jisheng, et al.
Publicado: (2016)

Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B
por: Pippa, Simone, et al.
Publicado: (2019)

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
por: Sun, Fei, et al.
Publicado: (2015)

Correction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2020)

Overexpression of Karyopherin 2 in Human Ovarian Malignant Germ Cell Tumor Correlates with Poor Prognosis
por: He, Li, et al.
Publicado: (2012)

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
por: Woopen, Hannah, et al.
Publicado: (2014)

Regulation of oncogenic PI3-kinase signaling by JARID1B
por: Facompre, Nicole D., et al.
Publicado: (2017)

DNA Methylation Signature for JARID2-Neurodevelopmental Syndrome
por: Verberne, Eline A., et al.
Publicado: (2022)

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma
por: Chen, Jie, et al.
Publicado: (2013)

Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
por: Markers, Disease
Publicado: (2023)

TRPV4 Overexpression Promotes Metastasis Through Epithelial–Mesenchymal Transition in Gastric Cancer and Correlates with Poor Prognosis
por: Wang, Huafeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1d7cratms0k1hn6vp4ceiatta